All In Biotech

Drug Trial Radar · NCT03402165

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Impact of Serum Alpha-fetoprotein Levels on the Response to Direct Antiviral Therapy in Egyptian Patients With Chronic Hepatitis C

Last checked: Nov 19, 2026Latest source record: Aug 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 1,200 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

1,200

Planned (sponsor's estimate)

Start

Jan 1, 2017

Primary completion

Dec 1, 2022

Study completion Dec 30, 2022

Sponsor

Lead sponsor
Sherief Abd-ElsalamAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 18, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Alpha-fetoprotein Levels on the Response to direct Antiviral Therapy in Patients with Chronic Hepatitis C

Conditions

  • Hepatitis C

Interventions

  • Sofosbuvir and Ledipasvir or sofosbuvir and daklatasuvirDrug

    Response to DAAD's and developing HCC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of patients with sustained virologic responseTime frame: 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sherief Abd-Elsalam

    Tanta, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.